Educate Your MP

File PhotoIn the past, science was a fringe issue for the public. More recently, however, debates over genetically modified food crops, cloning, and stem-cell therapy have stoked public fears. Politicians often add little to the debates because they don't understand the science; in turn, scientists' reticence adds to the public's bewilderment.With so much legislation now based on scientific research, scientists need to be involved in the decision-making. "I feel very strongly that scientists hav

Written byMartina Habeck
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

File Photo

In the past, science was a fringe issue for the public. More recently, however, debates over genetically modified food crops, cloning, and stem-cell therapy have stoked public fears. Politicians often add little to the debates because they don't understand the science; in turn, scientists' reticence adds to the public's bewilderment.

With so much legislation now based on scientific research, scientists need to be involved in the decision-making. "I feel very strongly that scientists have not gotten as involved as they should have done in many of the key issues," says Kathryn Arnold, research assistant at the Division of Environmental and Evolutionary Biology at the University of Glasgow.

The Medical Research Council is planning to require public communication as part of its grant criteria, and the UK Royal Society has run a program for three years to get scientists and politicians talking: the MP (Member of Parliament)-Scientist Pairing Scheme. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies